PT  - JOURNAL ARTICLE
AU  - Kitley, Joanna L.
AU  - Lachmann, Helen J.
AU  - Pinto, Ashwin
AU  - Ginsberg, Lionel
TI  - Neurologic manifestations of the cryopyrin-associated periodic syndrome
AID  - 10.1212/WNL.0b013e3181d9ed69
DP  - 2010 Apr 20
TA  - Neurology
PG  - 1267--1270
VI  - 74
IP  - 16
4099  - http://n.neurology.org/content/74/16/1267.short
4100  - http://n.neurology.org/content/74/16/1267.full
SO  - Neurology2010 Apr 20; 74
AB  - Background: The cryopyrin-associated periodic syndrome (CAPS) is a rare but treatable hereditary autoinflammatory condition. Without treatment, one third of patients develop amyloidosis with consequent renal failure and death. CAPS encompasses 3 conditions: familial cold autoinflammatory syndrome, Muckle–Wells syndrome, and chronic infantile, neurologic, cutaneous, and articular syndrome. Neurologic complications are common in children with the chronic infantile, neurologic, cutaneous, and articular phenotype, but there are no previous published reports of neurologic features in adults with milder phenotypes. Methods: In this case series, we report in detail an adult case of CAPS and summarize the neurologic features seen in 12 other adults with genetically proven CAPS. These patients participated in a recent randomized study of canakinumab in CAPS and we used pretreatment data collected in this study. Results: Twelve of the 13 patients (92%) had headache, of whom 10 (77%) had features of migraine. Seven patients (54%) had sensorineural deafness. Nine patients (69%) reported myalgia. Six patients (46%) had papilledema and a further 2 (15%) had optic disc pallor. MRI brain scan was normal in all patients. Conclusion: CAPS is a rare but treatable condition that may be encountered by neurologists in adult clinical practice since it can present with headache, myalgia, papilledema, sensorineural deafness, and aseptic meningitis. Unrecognized and untreated, it can lead to significant morbidity and mortality from renal failure. Treatment with anti-interleukin-1 therapy leads to complete resolution of symptoms and should also prevent progression to amyloidosis and subsequent renal failure. CAPS=cryopyrin-associated periodic syndrome; CINCA=chronic infantile neurologic, cutaneous, and articular syndrome; CRP=C-reactive protein; ESR=erythrocyte sedimentation rate; FCAS=familial cold autoinflammatory syndrome; MWS=Muckle-Wells syndrome.